Through the differential expression analysis, WGCNA analysis, and Cox regression analysis, our research identified a significant prognosis-related biomarker, BIRC5, which accurately predicted BFS in PCa patients and a high correlation with immune infiltrations. The gene discussed is BIRC5; the disease is posterior cortical atrophy.